RSHO vs. CANC

Last updated Jun 4, 2026

RSHO (Tema American Reshoring ETF) and CANC (Tema Oncology ETF) are both exchange-traded funds - RSHO is a Mid Cap Blend Equities fund actively managed by Tema, while CANC is a Health & Biotech Equities fund actively managed by Tema. Both are actively managed. Over the past 3 years, RSHO returned 31.02%/yr vs 107.76%/yr for CANC. At a 0.46 correlation, their price movements are largely independent. Both charge a 0.75% expense ratio.

Performance

RSHO vs. CANC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tema American Reshoring ETF (RSHO) and Tema Oncology ETF (CANC). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RSHO achieves a 33.69% return, which is significantly higher than CANC's 4.82% return.

RSHO

• 1D: 0.12%
• 1M: 7.69%
• YTD: 33.69%
• 6M: 33.85%
• 1Y: 57.71%
• 3Y*: 31.02%
• 5Y*: —
• 10Y*: —

CANC

• 1D: 0.08%
• 1M: -3.73%
• YTD: 4.82%
• 6M: 3.86%
• 1Y: 47.37%
• 3Y*: 107.76%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

RSHO vs. CANC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
RSHO Tema American Reshoring ETF	33.69%	19.23%	17.28%	28.26%
CANC Tema Oncology ETF	4.82%	42.92%	-5.37%	787.60%

Correlation

The correlation between RSHO and CANC is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.43
Correlation (3Y) Calculated over the trailing 3-year period	0.46
Correlation (All Time) Calculated using the full available price history since May 12, 2023	0.46

RSHO vs. CANC - Sectors Allocation Comparison

Sectors	RSHO	CANC
Industrials	73.1%	-
Technology	11.4%	-
Basic Materials	8.5%	-
Consumer Cyclical	3.7%	-
Energy	1.0%	-
Financial Services	0.9%	-
Communication Services	-	-
Consumer Defensive	-	-
Healthcare	-	100.0%
Real Estate	-	-
Utilities	-	-

Return for Risk

RSHO vs. CANC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RSHO

RSHO Risk / Return Rank: 73
RSHO Sharpe Ratio Rank: 74
RSHO Sortino Ratio Rank: 72
RSHO Omega Ratio Rank: 66
RSHO Calmar Ratio Rank: 77
RSHO Martin Ratio Rank: 78

CANC

CANC Risk / Return Rank: 69
CANC Sharpe Ratio Rank: 61
CANC Sortino Ratio Rank: 64
CANC Omega Ratio Rank: 54
CANC Calmar Ratio Rank: 90
CANC Martin Ratio Rank: 77

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RSHO vs. CANC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tema American Reshoring ETF (RSHO) and Tema Oncology ETF (CANC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	RSHO	CANC	Difference
Sharpe ratio: Return per unit of total volatility	2.44	2.06	+0.38
Sortino ratio: Return per unit of downside risk	3.28	2.96	+0.32
Omega ratio: Gain probability vs. loss probability	1.40	1.34	+0.07
Calmar ratio: Return relative to maximum drawdown	3.96	5.49	-1.53
Martin ratio: Return relative to average drawdown	15.16	14.62	+0.54
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

RSHO vs. CANC - Sharpe Ratio Comparison

The current RSHO Sharpe Ratio is 2.44, which is comparable to the CANC Sharpe Ratio of 2.06. The chart below compares the historical Sharpe Ratios of RSHO and CANC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	RSHO	CANC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.44	2.06	+0.38
Sharpe Ratio (All Time) Calculated using the full available price history	1.48	-0.04	+1.51

Drawdowns

RSHO vs. CANC - Drawdown Comparison

The maximum RSHO drawdown since its inception was -27.31%, smaller than the maximum CANC drawdown of -97.53%. Use the drawdown chart below to compare losses from any high point for RSHO and CANC.

Drawdown Indicators

	RSHO	CANC	Difference
Max Drawdown Largest peak-to-trough decline	-27.31%	-97.53%	+70.22%
Max Drawdown (1Y) Largest decline over 1 year	-14.64%	-8.67%	-5.97%
Max Drawdown (3Y) Largest decline over 3 years	-27.31%	-30.27%	+2.96%
Current Drawdown Current decline from peak	0.00%	-56.55%	+56.55%
Average Drawdown Average peak-to-trough decline	-4.32%	-73.19%	+68.87%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.82%	3.25%	+0.57%

Volatility

RSHO vs. CANC - Volatility Comparison

Tema American Reshoring ETF (RSHO) has a higher volatility of 9.22% compared to Tema Oncology ETF (CANC) at 6.26%. This indicates that RSHO's price experiences larger fluctuations and is considered to be riskier than CANC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RSHO	CANC	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.22%	6.26%	+2.96%
Volatility (6M) Calculated over the trailing 6-month period	20.09%	16.69%	+3.40%
Volatility (1Y) Calculated over the trailing 1-year period	23.74%	23.11%	+0.63%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	22.55%	280.27%	-257.72%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	22.55%	280.27%	-257.72%

RSHO vs. CANC - Expense Ratio Comparison

Both RSHO and CANC have an expense ratio of 0.75%.

Dividends

RSHO vs. CANC - Dividend Comparison

RSHO's dividend yield for the trailing twelve months is around 0.22%, more than CANC's 0.05% yield.

Position	TTM	2025	2024	2023
CANC Tema Oncology ETF	0.05%	0.06%	3.00%	0.56%
RSHO Tema American Reshoring ETF	0.22%	0.30%	0.26%	0.25%

Frequently Asked Questions

Can I hold both RSHO and CANC in my portfolio?

RSHO and CANC have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RSHO or CANC?

RSHO has higher volatility (9.22%) compared to CANC (6.26%). In terms of maximum drawdown, RSHO dropped -27.31% vs CANC's -97.53%.

Which ETF is better, RSHO or CANC?

On 3-year performance, CANC leads with 107.76% vs 31.02% for RSHO. Both ETFs have the same 0.75% expense ratio. On volatility, CANC has been the lower-risk option at 6.26%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, RSHO or CANC?

Over the 3-year period, CANC has performed better with a 107.76% return vs 31.02%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, RSHO or CANC?

RSHO and CANC have the same expense ratio: 0.75% per year.

Which ETF pays a higher dividend yield, RSHO or CANC?

RSHO has the higher dividend yield at 0.22%, compared with 0.05% for CANC.

What is the main difference between RSHO and CANC?

RSHO is categorized as Mid Cap Blend Equities, while CANC is Health & Biotech Equities.

Which has better risk-adjusted returns?

RSHO currently has the higher Sharpe Ratio (2.44 vs 2.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.